Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07576881 · ClinicalTrials.gov registry record · Phase 2
Impact of Standardization on Outcomes Following Cervical Ripening
A Phase 2 study, sponsored by Indiana University.
- Not yet
- Registry status
- Phase 2
- Development phase
- 1,158
- Enrollment target
NCT07576881: Clinical Trial Phase 2 study, sponsored by Indiana University.
NCT07576881 is a Phase 2 study that has not yet begun recruiting, run by Indiana University. The registered enrollment target is 1,158 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (771% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07576881, a Phase 2 study, has not yet begun recruiting, sponsored by Indiana University.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 1,158 participants
- Enrollment target
Study Summary
The primary purpose of this study is to determine if vaginal delivery rate is impacted by the use of standardized methods of cervical ripening. Additional outcomes will be evaluated including maternal and fetal outcomes of labor.
Primary Outcome
The primary outcome measure for this study is Spontaneous Vaginal Delivery (SVD) rate which is measured as the proportion of patients who deliver vaginally.
Interventions
- DEVICE Cervical Ripening with a double balloon catheter only
- COMBINATION_PRODUCT Cervical ripening with a double balloon catheter plus misoprostol
- COMBINATION_PRODUCT Usual-care control group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,158 participants |
| Start Date | 2026-06 |
| Est. Completion | 2028-04 |
| Phase | Phase 2 |
What is known before NCT07576881 opens enrollment
NCT07576881 is an interventional study that assigns participants to a tested intervention. Its 1,158 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (771% higher).
The record links to 0 conditions, and to 3 interventions - of which Cervical Ripening with a double balloon catheter only is the first listed.
NCT07576881 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07576881 about?
NCT07576881 is a clinical study titled "Impact of Standardization on Outcomes Following Cervical Ripening". The primary purpose of this study is to determine if vaginal delivery rate is impacted by the use of standardized methods of cervical ripening. Additional outcomes will be evaluated including maternal and fetal outcomes of labor.
What is the current status of trial NCT07576881?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 1,158 participants. The study started on 2026-06. Estimated completion is 2028-04.
What interventions are being tested in trial NCT07576881?
The interventions under investigation include: Cervical Ripening with a double balloon catheter only (DEVICE), Cervical ripening with a double balloon catheter plus misoprostol (COMBINATION_PRODUCT), Usual-care control group (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT07576881?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07576881's enrollment target sits among peer trials
1,158 19th of 2000 higher than 1,982 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04577599 · 1,160 participants · NA
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
- NCT07082738 · 1,160 participants · Phase 2
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- NCT07237048 · 1,164 participants · Phase 2
Minocycline in Stroke Study at Maimonides
- NCT04474301 · 1,152 participants
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia